• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Ambra ProViewer

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Ambra ProViewersee related information
Date Initiated by FirmJune 23, 2022
Date PostedSeptember 27, 2022
Recall Status1 Open3, Classified
Recall NumberZ-1818-2022
Recall Event ID 90817
510(K)NumberK202335 
Product Classification System, image processing, radiological - Product Code LLZ
ProductAmbra PACS, Ambra ProViewer. Software for use as a primary diagnostic and analysis tool for diagnostic images.
Code Information UDI-DI: AMBRHEALTHSOLUTIONS0; Software Version: 3.22.2.0 and 3.22.3.0.
FEI Number 3008776294
Recalling Firm/
Manufacturer
DICOM Grid, Inc. d/b/a Ambra Health
450 Park Ave S Fl 10-111
New York NY 10016-7320
For Additional Information ContactAmbra Support
888-315-0790
Manufacturer Reason
for Recall
A race condition between the storage system and services database has the potential to revert edits made to patient information upon first ingestion of a study.
FDA Determined
Cause 2
Software design
ActionThe firm distributed an Urgent Medical Device Recall Notice dated June 23, 2022, by email to affected customers. The firm informed customers that a race condition was identified between Ambra's storage system and the serivces database which has the potential to revert edits made to patient health information upon first ingestion of a study. This could lead to a possibility that incorrect patient ifnormation is presented to the physician, which would impact the decision making in regard to patient care. Customers are asked to advise all users of the system of this issue, request a patch from Ambra to be enabled on your system, and wait until all images for a given study are ingested before manually editing patient health information in the study. Ambra's actions include the deployment of a patch that is acting as a temporary fix until a software update can be deployed to all customers, which will prevent the issue from occurring in the future.
Quantity in Commerce671 downloads
DistributionDomestic: AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, DC, & PR.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
510(K) Database510(K)s with Product Code = LLZ
-
-